Logo image
Oral vs intratympanic corticosteroid therapy for idiopathic sudden sensorineural hearing loss: a randomized trial
Journal article   Open access   Peer reviewed

Oral vs intratympanic corticosteroid therapy for idiopathic sudden sensorineural hearing loss: a randomized trial

Steven D Rauch, Christopher F Halpin, Patrick J Antonelli, Seilesh Babu, John P Carey, Bruce J Gantz, Joel A Goebel, Paul E Hammerschlag, Jeffrey P Harris, Brandon Isaacson, …
JAMA : the journal of the American Medical Association, Vol.305(20), pp.2071-2079
05/25/2011
DOI: 10.1001/jama.2011.679
PMID: 21610239
url
https://doi.org/10.1001/jama.2011.679View
Published (Version of record) Open Access

Abstract

Idiopathic sudden sensorineural hearing loss has been treated with oral corticosteroids for more than 30 years. Recently, many patients' symptoms have been managed with intratympanic steroid therapy. No satisfactory comparative effectiveness study to support this practice exists.
Acute Disease Glucocorticoids - administration & dosage Prednisone - administration & dosage Prednisone - adverse effects Prospective Studies Administration, Oral Humans Middle Aged Male Methylprednisolone - adverse effects Treatment Outcome Young Adult Adolescent Aged, 80 and over Tympanic Membrane - drug effects Adult Female Aged Hearing Loss, Sensorineural - drug therapy Glucocorticoids - adverse effects Methylprednisolone - administration & dosage

Details

Logo image